Medication info
Glimepiride Tablet 2mg (Glimepiride)

Glimepiride Tablet 2mg (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Green oblong tablets
Packaging
30 tablets/box [10 tablets/PTPX3], 100 tablets/bottle
Approval status
Active

MFDS item code 200301831 · Notified 2003.12.13 · Insurance code 643500120

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow whole without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1–2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral antihyperglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral antihyperglycemic agents. When switching from another oral antihyperglycemic agent to this medicine, it is recommended to follow the instructions under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1–2-week intervals. The efficacy and duration of action of the previous medicine should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediately taking sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the dose of each medicine may be adjusted to achieve the desired blood glucose level. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant use of this medicine and metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It acts as an adjunct to dietary and physical exercise therapies and can be administered alone. However, if blood sugar control is insufficient, it may be used in combination with other oral hypoglycemic agents or insulin. Combination therapy is especially recommended for patients who have difficulty controlling blood sugar levels with sulfonylureas or metformin. This medication is effective in controlling blood sugar levels and aiding in diabetes management.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow whole without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1–2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral antihyperglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral antihyperglycemic agents. When switching from another oral antihyperglycemic agent to this medicine, it is recommended to follow the instructions under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1–2-week intervals. The efficacy and duration of action of the previous medicine should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediately taking sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the dose of each medicine may be adjusted to achieve the desired blood glucose level. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant use of this medicine and metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes mellitus or diabetic ketoacidosis, or in patients who are in diabetic coma. Patients with an allergy to this drug or sulfonylureas or sulfonamides should also avoid its use. Since this medication contains lactose, individuals with lactose intolerance or genetic galactose metabolism disorders should not take it. Patients with severe hepatic or renal impairment should avoid using this medication, and in such cases, switching to insulin therapy is recommended. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients with severe infections, those who have recently undergone surgery, or those who have suffered major trauma should also receive insulin therapy instead of this medication. Care should be taken as gastrointestinal disturbances such as vomiting or diarrhea can lead to hypoglycemia due to improper food absorption. In the first week of taking this medication, there is a heightened risk of hypoglycemia, so blood sugar levels should be closely monitored. Particularly, seniors, individuals with poor nutritional status, those who eat irregularly, engage in excessive exercise, or have changes in food intake should be especially cautious. Individuals who frequently consume alcohol or have impaired renal or hepatic function may also have an increased risk of hypoglycemia. Caution is also advised in cases of overdose or certain endocrine disorders, as the risk of hypoglycemia can be elevated. Symptoms of hypoglycemia may include headaches, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, decreased consciousness, and more, necessitating immediate consumption of sugar if such symptoms occur. During the course of taking this medication, blurred vision, digestive discomfort, abdominal pain, liver dysfunction, hematological disturbances, or allergic reactions may occur, and if any unusual symptoms arise, consult your doctor. If a severe allergic reaction occurs, discontinue the medication immediately and seek medical help. It is extremely important to maintain a regular diet, exercise, and weight management while taking this medication, and it is advised to always carry sugar for quick response to hypoglycemia. If taking other medications, these may affect blood sugar, so always inform your healthcare provider about any other medications you are on. Pregnant or nursing women should avoid the use of this medication and opt for other alternatives such as insulin therapy if necessary. This medication is not recommended for children under 18 years of age, as safety and efficacy have not been established. In seniors, special attention should be paid to dosage adjustments due to potential decreased renal function. In the event of overdose, hypoglycemia may worsen, requiring immediate emergency treatment, which may involve inducing vomiting, gastric lavage, or glucose injection.

Side effects

Hypoglycemia, headache, intense hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech disorders, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, venous arrhythmia, blurred vision, fullness or pressure sensation in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius to safely preserve the medication's efficacy.

Appearance and packaging

Appearance

Green oblong tablets

Package unit

30 tablets/box [10 tablets/PTPX3], 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.